Surrozen (SRZN) Assets Average (2020 - 2026)

Surrozen (SRZN) recorded quarterly Assets Average of $109.7 million in Q1 2026, up 13.83% quarter-over-quarter from $96.4 million in Q4 2025, and up 34.38% on a YoY basis from $81.6 million in Q1 2025.

Surrozen (SRZN) Assets Average (2020 - 2026) Analysis & Trends

Surrozen's Assets Average history runs 7 years deep, the most recent figure standing at $109.7 million for Q1 2026.

  • In Q1 2026, Assets Average rose 34.38% year-over-year to $109.7 million; the TTM figure through Mar 2026 stood at $109.7 million (up 34.38% YoY), while the FY2025 annual figure was $73.6 million, up 55.68% from the prior year.
  • Assets Average was $109.7 million for Q1 2026 at Surrozen, up from $96.4 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $127.4 million in Q1 2022 to a low of $40.9 million in Q2 2024.
  • Historically, Assets Average has averaged $79.9 million across 5 years, with a median of $81.8 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Assets Average slumped 49.4% in 2024, then soared 165.97% in 2025.
  • A 5-year view of Assets Average shows it stood at $90.4 million in 2022, then tumbled by 44.68% to $50.0 million in 2023, then declined by 3.59% to $48.2 million in 2024, then surged by 99.84% to $96.4 million in 2025, then climbed by 13.83% to $109.7 million in 2026.
  • The last three Assets Average figures came in at $109.7 million (Q1 2026), $96.4 million (Q4 2025), and $98.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 33.42 Mn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 795.91 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 13.04 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 1.72 Bn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 40.89 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - 26.03 Mn
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 10.06 Mn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 26.06 Bn
9 Abivax 94.37 Bn 94.37 Bn - 660.38 Mn
10 Surrozen 225,877.86 -106.68 Mn - 109.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 109.72 Mn
Dec 31, 2025 96.39 Mn
Sep 30, 2025 98.37 Mn
Jun 30, 2025 108.76 Mn
Mar 31, 2025 81.65 Mn
Dec 31, 2024 48.23 Mn
Sep 30, 2024 46.53 Mn
Jun 30, 2024 40.89 Mn
Mar 31, 2024 41.40 Mn
Dec 31, 2023 50.03 Mn
Sep 30, 2023 58.99 Mn
Jun 30, 2023 69.10 Mn
Mar 31, 2023 81.82 Mn
Dec 31, 2022 90.43 Mn
Sep 30, 2022 97.78 Mn
Jun 30, 2022 110.89 Mn
Mar 31, 2022 127.41 Mn
Dec 31, 2021 143.91 Mn
Sep 30, 2021 121.79 Mn
Jun 30, 2021 93.19 Mn